CCL17 production by dendritic cells is required for NOD1-mediated exacerbation of allergic asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 8, 2014, Pages 899-908

  Yahia, Saliha Ait ^a,b,c,d   Azzaoui, Imane ^a,b,c,d   Everaere, Laetitia ^a,b,c,d   Vorng, Han ^a,b,c,d   Chenivesse, Cecile ^a,b,c,d   Marquillies, Philippe ^a,b,c,d   Duez, Catherine ^a,b,c,d   Delacre, Myriam ^b,c,d,e   Grandjean, Teddy ^b,c,d,e   Balsamelli, Joanne ^a,b,c,d   Fanton d'Andon, Martine ^f,g   Fan, Ying ^a,b,c,d   Ple, Coline ^a,b,c,d   Werts, Catherine ^f,g   Boneca, Ivo Gomperts ^f,g   Wallaert, Benoit ^a,b,c,d   Chamaillard, Mathias ^b,c,d,e   Tsicopoulos, Anne ^a,b,c,d  

^a Pulmonary Immunity Institut National de la Sante et de la Recherche Me dicale   (France)

^b INSERM U1019   (France)

^c Le Centre National de la Recherche Scientifique Unite s Mixtes de Recherche   (France)

^d UNIV LILLE   (France)

^e Nods like receptors in infection and immunity Institut National de la Sante et de la Recherche Me dicale   (France)

^f INSTITUT PASTEUR   (France)

^g INSERM   (France)

Author keywords

Adjuvant; Asthma; Chemokine; Pattern recognition receptor

Indexed keywords

ALLERGENS; ANIMALS; ASTHMA; CHEMOKINE CCL17; CHEMOKINE CCL22; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; NOD1 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMORPHISM, GENETIC; TH2 CELLS; UP-REGULATION;

EID: 84898946786     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201310-1827OC     Document Type: Article

References (42)

1. Opitz B, van Laak V, Eitel J, Suttorp N. Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med 2010;181:1294-1309.
2. Levitz SM, Golenbock DT. Beyond empiricism: informing vaccine development through innate immunity research. Cell 2012;148: 1284-1292.
3. Rastogi R, Du W, Ju D, Pirockinaite G, Liu Y, Nunez G, Samavati L. Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells. Am J Respir Crit Care Med 2011;183:500-510.
4. Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, Kufer TA, Collins C, Viala J, Ferrero RL, Girardin SE, et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 2007;26:445-459.
5. Chamaillard M, Girardin SE, Viala J, Philpott DJ. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 2003;5:581-592.
6. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jé hanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003;300:1584-1587.
7. Cartwright N, Murch O, McMaster SK, Paul-Clark MJ, van Heel DA, Ryffel B, Quesniaux VF, Evans TW, Thiemermann C, Mitchell JA. Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo. Am J Respir Crit Care Med 2007;175:595-603.
8. Uehara A, Fujimoto Y, Fukase K, Takada H. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 2007;44:3100-3111.
9. Fritz JH, Girardin SE, Fitting C, Werts C, Mengin-Lecreulx D, Caroff M, Cavaillon JM, Philpott DJ, Adib-Conquy M. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol 2005;35: 2459-2470.
10. Hysi P, Kabesch M, Moffatt MF, Schedel M, Carr D, Zhang Y, Boardman B, von Mutius E, Weiland SK, Leupold W, et al. NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 2005;14: 935-941.
11. Weidinger S, Klopp N, Rummler L, Wagenpfeil S, Novak N, Baurecht HJ, Groer W, Darsow U, Heinrich J, Gauger A, et al. Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol 2005;116:177-184.
12. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrlander C, Nowak D, Holst O, Martinez FD; ALEX-Team. Association between exposure to farming, allergies and genetic variation in CARD4/NOD1. Allergy 2006;61:1117-1124.
13. Bogefors J, Rydberg C, Uddman R, Fransson M, Ma nsson A, Benson M, Adner M, Cardell LO. Nod1, Nod2 and Nalp3 receptors, new potential targets in treatment of allergic rhinitis? Allergy 2010;65: 1222-1226.
14. Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009;31:412-424.
15. Ait Yahia S, Azzaoui I, Vorng H, Marquillies P, Duez C, Delacre M, Grandjean T, Glineur C, Everaere L, Fan Y, et al. CCL17 production by dendritic cells is required for NOD1-mediated exacerbation of allergic asthma [abstract]. Presented at the Keystone Symposium: Type 2 immunity and pathogenic processes in asthma and COPD, Santa Fe, NM, January 10-15, 2013.
16. Azzaoui I, Yahia SA, Chang Y, Vorng H, Morales O, Fan Y, Delhem N, Ple C, Tonnel AB, Wallaert B, et al. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects. Blood 2011;118:3549-3558.
17. Chang Y, de Nadai P, Azzaoui I, Morales O, Delhem N, Vorng H, Tomavo S, Ait Yahia S, Zhang G, Wallaert B, et al. The chemokine CCL18 generates adaptive regulatory T cells from memory CD41 T cells of healthy but not allergic subjects. FASEB J 2010;24: 5063-5072.
18. Chenivesse C, Chang Y, Azzaoui I, Ait Yahia S, Morales O, Plé C, Foussat A, Tonnel AB, Delhem N, Yssel H, et al. Pulmonary CCL18 recruits human regulatory T cells. J Immunol 2012;189: 128-137.
19. Biet F, Duez C, Kremer L, Marquillies P, Amniai L, Tonnel AB, Locht C, Pestel J. Recombinant Mycobacterium bovis BCG producing IL-18 reduces IL-5 production and bronchoalveolar eosinophilia induced by an allergic reaction. Allergy 2005;60:1065-1072.
20. Ple C, Barrier M, Amniai L, Marquillies P, Bertout J, Tsicopoulos A, Walzer T, Lassalle P, Duez C. Natural killer cells accumulate in lungdraining lymph nodes and regulate airway eosinophilia in a murine model of asthma. Scand J Immunol 2010;72:118-127.
21. Sé né chal S, de Nadai P, Ralainirina N, Scherpereel A, Vorng H, Lassalle P, Tonnel AB, Tsicopoulos A, Wallaert B. Effect of diesel on chemokines and chemokine receptors involved in helper T cell type 1/type 2 recruitment in patients with asthma. Am J Respir Crit Care Med 2003;168:215-221.
22. Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, Peyrin-Biroulet L, Lemoine Y, Hot D, Chamaillard M. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci USA 2011;108:9601-9606.
23. Ryman KD, White LJ, Johnston RE, Klimstra WB. Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis. Viral Immunol 2002;15:53-76.
24. Tada H, Aiba S, Shibata K, Ohteki T, Takada H. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect Immun 2005;73:7967-7976.
25. Cappello P, Fraone T, Barberis L, Costa C, Hirsch E, Elia AR, Caorsi C, Musso T, Novelli F, Giovarelli M. CC-chemokine ligand 16 induces a novel maturation program in human immature monocytederived dendritic cells. J Immunol 2006;177:6143-6151.
26. Marsland BJ, Battig P, Bauer M, Ruedl C, Lassing U, Beerli RR, Dietmeier K, Ivanova L, Pfister T, Vogt L, et al. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 2005;22:493-505.
27. Magalhaes JG, Philpott DJ, Nahori MA, Jé hanno M, Fritz J, Le Bourhis L, Viala J, Hugot JP, Giovannini M, Bertin J, et al. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep 2005;6:1201-1207.
28. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002;196: 1645-1651.
29. Piggott DA, Eisenbarth SC, Xu L, Constant SL, Huleatt JW, Herrick CA, Bottomly K. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J Clin Invest 2005;115:459-467.
30. Werts C, le Bourhis L, Liu J, Magalhaes JG, Carneiro LA, Fritz JH, Stockinger S, Balloy V, Chignard M, Decker T, et al. Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway. Eur J Immunol 2007;37:2499-2508.
31. Penna G, Vulcano M, Roncari A, Facchetti F, Sozzani S, Adorini L. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 2002;169:6673-6676.
32. Sekiya T, Miyamasu M, Imanishi M, Yamada H, Nakajima T, Yamaguchi M, Fujisawa T, Pawankar R, Sano Y, Ohta K, et al. Inducible expression of a Th2-type CC chemokine thymus- and activationregulated chemokine by human bronchial epithelial cells. J Immunol 2000;165:2205-2213.
33. Nakayama T, Hieshima K, Nagakubo D, Sato E, Nakayama M, Kawa K, Yoshie O. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 2004;78:1665-1674.
34. Hirata H, Arima M, Cheng G, Honda K, Fukushima F, Yoshida N, Eda F, Fukuda T. Production of TARC and MDC by naive T cells in asthmatic patients. J Clin Immunol 2003;23:34-45.
35. Lambrecht BN, Pauwels RA, Fazekas De St Groth B. Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J Immunol 2000;164: 2937-2946.
36. Girardin SE, Jé hanno M, Mengin-Lecreulx D, Sansonetti PJ, Alzari PM, Philpott DJ. Identification of the critical residues involved in peptidoglycan detection by Nod1. J Biol Chem 2005;280: 38648-38656.
37. Medoff BD, Seung E, Hong S, Thomas SY, Sandall BP, Duffield JS, Kuperman DA, Erle DJ, Luster AD. CD11b1 myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation. J Immunol 2009;182:623-635.
38. Perros F, Hoogsteden HC, Coyle AJ, Lambrecht BN, Hammad H. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation. Allergy 2009;64:995-1002.
39. Henry CJ, Ornelles DA, Mitchell LM, Brzoza-Lewis KL, Hiltbold EM. IL- 12 produced by dendritic cells augments CD81 T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol 2008;181:8576-8584.
40. Alferink J, Lieberam I, Reindl W, Behrens A,Weiss S, Huser N, Gerauer K, Ross R, Reske-Kunz AB, Ahmad-Nejad P, et al. Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J Exp Med 2003; 197:585-599.
41. Magalhaes JG, Rubino SJ, Travassos LH, Le Bourhis L, Duan W, Sellge G, Geddes K, Reardon C, Lechmann M, Carneiro LA, et al. Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation. Proc Natl Acad Sci USA 2011;108:14896-14901.
42. Duan W, Mehta AK, Magalhaes JG, Ziegler SF, Dong C, Philpott DJ, Croft M. Innate signals from Nod2 block respiratory tolerance and program T(H)2-driven allergic inflammation. J Allergy Clin Immunol 2010;126:1284-1293, e10.